Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Ovid's lead drug shows promising efficacy signal in Fragile X syndrome study, but optimal dosing regimen is unclear for path forward
Endpoints
Fri, 05/8/20 - 10:34 am
Tags:
Ovid Therapeutics, Takeda, Lundbeck, Fragile X syndrome, clinical trials
Takeda gets FDA breakthrough therapy status for mobocertinib to treat certain type of lung cancer
Pharmaceutical Business Review
Tue, 04/28/20 - 11:45 pm
Tags:
Takeda, FDA, mobocertinib, metastatic non-small cell lung cancer
Takeda licenses ProThera plasma drug for use in inflammatory conditions
Fierce Biotech
Fri, 04/24/20 - 11:07 am
Tags:
Takeda, ProThera Biologics, inflammatory diseases, plasma-based pharmaceuticals
Takeda to sell European OTC business to cut debts
Pharmaforum
Fri, 04/24/20 - 10:53 am
Tags:
Takeda, Europe, debt, OTC
Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process
BioPharma Dive
Wed, 04/8/20 - 10:33 am
Tags:
Takeda, CSL, COVID-19, plasma, drug development
Biopharma acquisitions slow, but it's not Covid-19's fault yet
EP Vantage
Wed, 04/8/20 - 10:28 am
Tags:
M&A, COVID-19, Gilead Sciences, Forty Seven, Eli Lilly, Dermira, Takeda, Hypera Pharma, ANI Pharmaceuticals, Amerigen Pharma
Takeda and Evotec Enter into Gene Therapy Research Alliance
BioSpace
Mon, 04/6/20 - 09:43 pm
Tags:
Takeda, Evotec, gene therapy, R&D
Takeda signs $882m rare disease alliance with Oxford biotech Evox
Pharmaforum
Fri, 03/27/20 - 10:34 am
Tags:
Evox Therapeutics, Takeda, Rare Diseases, biotech
Bayer inks up with “small” Indian biotech for new approach at an old target
Endpoints
Mon, 03/23/20 - 11:31 am
Tags:
Bayer, Curadev, Takeda, R&D, India
2 newer multiple myeloma drugs fall short in bid for wider market
BioPharma Dive
Tue, 03/10/20 - 11:58 am
Tags:
Multiple Myeloma, clinical trials, Bristol-Myers Squibb, Takeda, Ninlaro, Empliciti, Revlimid
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Sun, 03/8/20 - 11:26 pm
Tags:
Gilead Sciences, GSK, Innovio, JNJ, Moderna Therapeutics, Regeneron, Sanofi, Takeda, Vir Biotchnology
Takeda and Arcturus join hunt for coronavirus therapies
Pharmaforum
Thu, 03/5/20 - 10:50 am
Tags:
Takeda, Arcturus, COVID-19, coronavirus, drug development
Can reformulation of an AstraZeneca castoff rival Takeda's new heartburn drug? Here's a $26M bet on yes
Endpoints
Wed, 03/4/20 - 07:55 pm
Tags:
Cinclus Pharma, AstraZeneca, heartburn, linaprazan, Takeda, acid reflux
Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million
BioSpace
Wed, 02/26/20 - 10:34 am
Tags:
Takeda, PvP Biologics, celiac disease, M&A, TAK-062
Takeda’s ALUNBRIG gets FDA priority review for expanded indication in NSCLC
Pharmaceutical Business Review
Tue, 02/25/20 - 10:19 am
Tags:
Takeda, Alunbrig, brigatinib, FDA, priority review, non-small cell lung cancer
Novimmune unit nabs Takeda milestone payment for hemophilia work
Fierce Biotech
Fri, 02/14/20 - 10:40 am
Tags:
Takeda, Light Chain Bioscience, Novimmune, R&D, Hemlibra, hemophilia A
Takeda invests in patient-centric data firm Seqster
Pharmaforum
Thu, 02/13/20 - 10:42 am
Tags:
Takeda, Seqster, startups, patients, digital health, EHRs
MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner
Endpoints
Thu, 02/6/20 - 11:50 am
Tags:
Takeda, MD Anderson, natural killer cell therapy, CAR-T
Takeda Pharmaceutical Raises Its Profit Outlook
Motley Fool
Tue, 02/4/20 - 11:21 pm
Tags:
Takeda, earnings, Shire
Takeda puts Shire biologics plant with 200 employees on the block
Fierce Pharma
Fri, 01/31/20 - 11:00 am
Tags:
Shire, Takeda, drug manufacturing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.